What Is CL Fair Value?
Colgate-Palmolive Company (CL) fair value estimate using multiple valuation models, updated daily.
As of August 1, 2026, Colgate-Palmolive Company (CL) has a composite fair value estimate of $67.36 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $91.30, suggesting the stock is overvalued by 26.2%.
Data as of August 1, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$67.36
vs. current price of $91.30(-26.2%)
How Is CL Fair Value Calculated?
Four independent models estimate what CL is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CL Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$117.48
+28.7%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$56.43
-38.2%Overvalued
Inputs used
CL Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$3.94
-95.7%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$38.14
-58.2%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $91.30 is 28.7% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $3.48B | $3.28B |
| Year 2 | $3.65B | $3.24B |
| Year 3 | $3.82B | $3.21B |
| Year 4 | $4.01B | $3.17B |
| Year 5 | $4.20B | $3.13B |
| Year 6 | $4.40B | $3.10B |
| Year 7 | $4.61B | $3.06B |
| Year 8 | $4.84B | $3.03B |
| Year 9 | $5.07B | $2.99B |
| Year 10 | $5.31B | $2.96B |
| Terminal Value | $154.36B | $85.97B |
What Are CL's Key Financial Metrics?
Earnings & Growth
Current Price
$91.30
EPS (TTM)
$2.54
Forward P/E
22.5
Profit Margin
10.0%
Cash & Balance Sheet
Free Cash Flow
3.3B
EBITDA
4.9B
Book Value
$0.18
Total Debt
8B
What Do Analysts Say About CL?
Low
$85.00
Average
$97.65
High
$110.00
Upside
+7.0%
CL Fair Value FAQ
What is the fair value of CL?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CL's estimated fair value is $67.36. The stock is currently trading at $91.30, which makes it overvalued by our analysis.
How is CL's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CL overvalued or undervalued?
Based on our analysis, CL is overvalued. The current price of $91.30 is 26.2% above our estimated fair value of $67.36.
What do Wall Street analysts say about CL?
20 analysts cover Colgate-Palmolive Company with a consensus rating of "Buy." The average price target is $97.65, ranging from $85.00 to $110.00. This implies 7.0% upside from the current price.